Cencora, Inc. Common Stock (COR) stock analysis
COR · Cencora, Inc. Common Stock
Latest recorded price: USD 357.00
Model-estimated fair value: USD 269.37. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Distribution
At $357.00, COR trades 32.5% above the model's base-case value of $269.37. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $202.62 in the conservative case and $347.20 in the optimistic case, with a valuation confidence score of 81/100. About 76% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 10.4%, free cash flow margin 1.0%, ROIC 19.2%. The model does not flag any risk signals for this company.
Similar companies in Healthcare
- Henry Schein, Inc. - Common Stock (HSIC)
- McKesson Corporation (MCK)
- Cardinal Health, Inc. (CAH)
- Corcept Therapeutics Incorporated - Common Stock (CORT)
- Charles River Laboratories International, Inc. (CRL)
- Cronos Group Inc. (CRON)
- CRISPR Therapeutics AG - Common Shares (CRSP)
- Castle Biosciences, Inc. (CSTL)